SCHEMBL4537427

SCHEMBL4537427

O=C(CC1CCCN(S(=O)(=O)c2ccccc2)C1)NC12CC3CC(CC(C3)C1)C2

nearest known ligand 0.52

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.52
NPC1 O15118 1/20 0.52
RAB9A P51151 1/20 0.52
KMT2A Q03164 1/20 0.52
EPHX1 P07099 5/20 0.48
CYP2C19 P33261 2/20 0.46
LMNA P02545 4/20 0.46
TSHR P16473 1/20 0.45
ALOX12 P18054 1/20 0.45
HTT P42858 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45
ALDH1A1 P00352 1/20 0.45
CYP3A4 P08684 1/20 0.45
DPP4 P27487 2/20 0.44
EPHX2 P34913 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4540431 0.95 NPC1 (0.55) SMN1; SMN2NPC1RAB9AKMT2AEPHX1
SCHEMBL8048283 0.90 SMN1; SMN2 (0.42) SMN1; SMN2NPC1RAB9AKMT2AEPHX1
SCHEMBL4530361 0.90 CYP3A4 (0.59) SMN1; SMN2KMT2AEPHX1CYP2C19LMNA
SCHEMBL4537575 0.90 ALDH1A1 (0.49) RAB9AKMT2AEPHX1CYP2C19LMNA
SCHEMBL4537343 0.90 LMNA (0.59) SMN1; SMN2KMT2AEPHX1CYP2C19LMNA
SCHEMBL4543052 0.89 NPC1 (0.48) SMN1; SMN2NPC1RAB9AKMT2AEPHX1
SCHEMBL4539317 0.88 HSD11B1 (0.49) SMN1; SMN2NPC1RAB9AKMT2AEPHX1
SCHEMBL4537048 0.88 LMNA (0.47) SMN1; SMN2NPC1RAB9AKMT2AEPHX1
SCHEMBL4539395 0.88 LMNA (0.47) KMT2AEPHX1CYP2C19LMNATSHR
SCHEMBL4542094 0.88 NPC1 (0.57) SMN1; SMN2NPC1RAB9AKMT2AEPHX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009070497-A1 SEH AND 11 β-HSD1 INHIBITORS AND THEIR USE SMITHKLINE BEECHAM CORPORATION (US) 2009-06-04 WO claimed
WO-2009070497-A1 SEH AND 11 β-HSD1 INHIBITORS AND THEIR USE SMITHKLINE BEECHAM CORPORATION (US) 2009-06-04 WO disclosed